05 May 2021 8 Min Read
Lilly accused of substandard quality control at Covid-19 drug factories
Employees have claimed an executive doctored documents to make the pharmaceutical giant look better
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In